Alveus Therapeutics ApS
CVR 44689790 · Private limited company (ApS) · Active · Low risk
Alveus Therapeutics ApS is a Private limited company (ApS), founded on , based in København K. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.1 times the average for Danish companies. 2 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 59.7m and a net result of DKK 2.1m.
Bankruptcy risk for Alveus Therapeutics ApS
0.1 × the average (1.41%) · higher risk than 38% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 44689790
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (2 years)
- Address
- Palægade 4, 3. th
1261 København K - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 60k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 2 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 91.6% |
| Current ratio | 1,190% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 5 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 17 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 22.1m | DKK -969k |
| Net profit | DKK 2.1m | DKK -5.6m |
| Equity | DKK 59.7m | DKK -5.6m |
| Total assets | DKK 65.1m | DKK 480k |
| Cash | DKK 63.4m | – |
| Short-term debt | DKK 5.4m | – |
| Avg. employees | 2 | – |
Latest annual report: Reporting class B · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 174 | ||
| 5 Mar 2024 – 31 Dec 2024 | 168 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Lars Peter Brunse | ||
| CEO | Marie Louise Lindegaard | ||
| CEO | Erik Voorspoels | ||
| Owner (5%) | FPCI BioDiscovery 7 | Current | |
| Owner (67%) | Alveus Therapeutics Inc. | Current | |
| Owner (5%) | Jeito II S.L.P | Current | |
| Owner (5%) | Novo Holdings A/S | Current | |
| Owner (5%) | Kurma Biofund IV FPCI | Current | |
| Owner (50%) | New Rhein Healthcare 2021 Lux SCSP | ||
| Owner (33%) | New Rhein Healthcare 2021 de LP | ||
| Owner (100%) | Alveus Therapeutics Inc. | ||
| Owner (90%) | Alveus Therapeutics Inc. | ||
| Founder | New Rhein Healthcare 2021 Lux SCSP | Current | |
| Founder | New Rhein Healthcare 2021 de LP | Current |
The CEOs' other companies
Lars Peter Brunse – 3 other companies
- FARMACEUTISK LABORATORIUM FERRING A/S Active
- FERRING HOLDING DANMARK A/S Fusioneret
- SYNTESE A/S Active
Address history (1 moves)
| Palægade 4, 3. th, 1261 København K | |
| Bredgade 6, 4., 1260 København K |
Other companies at the same address
- BRANDBART ApS Bankrupt
- BUREAUET 2012 A/S Bankrupt
- IMAGINEERING ApS Bankrupt
- C-SOLUTIONS HOLDING ApS Active
- COMPAYA A/S Active
- DET ELEKTRONISKE BIBLIOTEK A/S Fusioneret
- Flora Danica Jewellery Holding ApS Active
- GLISBY ApS Active
- Glænø Gods ApS Active
- HAFNIA EQUITY MANAGEMENT A/S Opløst
- Joelle Blok Holding ApS Active
- Occhio Scandinavia ApS Active
- SIGNFORM DANMARK A/S Fusioneret
- SONNY HOLDING ApS Active
- T.P.T. Foods ApS Active
- T.P.T. GROUP ApS Active
- T.P.T. HOLDING ApS Active
Similar companies in København
- CARLSBERG A/S København V
- CuraVision ApS København V
- Launch Bioindustries ApS København Ø
- RheumaLogics ApS København Ø
- Vitibiotech ApS København N
- Pyovita ApS Hellerup
- ArcanaBio ApS København N
- OvartiX ApS København N
- Keystone Consulting ApS København SV
- KPL ApS København N
- Cambiotics ApS København N
- Polyceutix ApS København N
Questions and answers about Alveus Therapeutics ApS
Has Alveus Therapeutics ApS gone bankrupt?
No, Alveus Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Alveus Therapeutics ApS?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.
When was Alveus Therapeutics ApS founded?
Alveus Therapeutics ApS was founded on 5 March 2024.
What is the equity of Alveus Therapeutics ApS?
Equity was DKK 59.7m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.